CANNBIOREX PHARMA LIMITED
Company number 11331809 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
-£10,923,481
Balance sheet as at 2024-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2018-04-26
- Employees
- 1 (2024 accounts)
- Registered office
- 71-75 Shelton Street, Covent Garden, London, United Kingdom, WC2H 9JQ
- Postcode
- WC2H 9JQ
- Capital
- 1 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-04-25
- Next due by
- 2027-05-09
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 3 current · 3 resigned
Group structure
Controlled by Cannbiorex Pharmaceuticals Corp (BC1155834) — since 2018-05-04
From persons-with-significant-control filings on the public register.
Contact details
- Website
- cannbiorex.com
欢迎莅临「9479威尼斯」全新升级官方网站,2023信誉品牌网址,游戏大厅支持最新在线路检测中心,提供手机版APP官方网页客户端下载安装注册,欢迎您的访问!
Previous registered addresses 3
| Address | Changed on |
|---|---|
| 601 INTERNATIONAL HOUSE 223 REGENT STREET, LONDON, W1B 2QD, ENGLAND | 2020-02-24 |
| NORTH WEST HOUSE 119 MARYLEBONE ROAD, LONDON, NW1 5PU, ENGLAND | 2019-12-17 |
| 601 INTERNATIONAL HOUSE 223 REGENT STREET, LONDON, W1B 2QD, UNITED KINGDOM | 2019-04-05 |
Among its peers
Among the oldest 25%
of 214 similar companies in WC, trading since 2018
Competitors London
-
3. NEWALR&D LTD
-
5. SENTCELL LTD
This company ranks 111 among research and experimental development on biotechnology in London.
The class of 2018
36%
of the 439 companies in this sector incorporated in 2018 are still active today; 60% have since been dissolved.
A fact about the year, not a forecast for this company.